Syndax Pharmaceuticals (SNDX) Non Operating Income (2015 - 2026)
Syndax Pharmaceuticals (SNDX) posted quarterly Non Operating Income of -$8.5 million for Q1 2026, down 677.87% year-over-year from $1.5 million in Q1 2025, and down 54.98% quarter-over-quarter from -$5.5 million in Q4 2025.
Syndax Pharmaceuticals (SNDX) Non Operating Income (2015 - 2026) Analysis & Trends
Syndax Pharmaceuticals' Non Operating Income history runs 12 years deep, the most recent figure standing at -$8.5 million for Q1 2026.
- In Q1 2026, Non Operating Income fell 677.87% year-over-year to -$8.5 million; the TTM figure through Mar 2026 stood at -$19.7 million (down 255.14% YoY), while the FY2025 annual figure was -$12.3 million, down 158.99% from the prior year.
- Non Operating Income for Q1 2026 stood at -$8.5 million, down from -$5.5 million in the prior quarter.
- The five-year high for Non Operating Income was $7.1 million in Q1 2024, with the low at -$8.5 million in Q1 2026.
- The 5-year median for Non Operating Income is $2.2 million (2024), against an average of $1.4 million.
- The sharpest annual moves came in 2023 and 2026: Non Operating Income soared 3230.92% in 2023, then sank 677.87% in 2026.
- Syndax Pharmaceuticals' Non Operating Income stood at $2.8 million in 2022, then soared by 91.33% to $5.4 million in 2023, then sank by 59.57% to $2.2 million in 2024, then plunged by 348.91% to -$5.5 million in 2025, then tumbled by 54.98% to -$8.5 million in 2026.
- Business Quant data shows SNDX's Non Operating Income at -$8.5 million in Q1 2026, -$5.5 million in Q4 2025, and -$3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Syndax Pharmaceuticals | 1.77 Bn | 1.22 Bn | 60.67 Mn | -9.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.37 Mn |
| Mar 31, 2026 | -8.47 Mn |
| Dec 31, 2025 | -5.47 Mn |
| Sep 30, 2025 | -3.29 Mn |
| Jun 30, 2025 | -2.49 Mn |
| Mar 31, 2025 | -1.09 Mn |
| Dec 31, 2024 | 2.20 Mn |
| Sep 30, 2024 | 5.45 Mn |
| Jun 30, 2024 | 6.15 Mn |
| Mar 31, 2024 | 7.11 Mn |
| Dec 31, 2023 | 5.43 Mn |
| Sep 30, 2023 | 5.21 Mn |
| Jun 30, 2023 | 5.06 Mn |
| Mar 31, 2023 | 4.89 Mn |
| Dec 31, 2022 | 2.84 Mn |
| Sep 30, 2022 | 262,000.00 |
| Jun 30, 2022 | 152,000.00 |
| Mar 31, 2022 | -311,000.00 |
| Dec 31, 2021 | 449,000.00 |
| Sep 30, 2021 | -607,000.00 |